NCT05461586 is a clinical trial of Refractive Technique (MR #1) in Refractive Error, sponsored by Johnson & Johnson Surgical Vision, Inc..

Who is sponsoring NCT05461586?

NCT05461586 is sponsored by Johnson & Johnson Surgical Vision, Inc..

What drugs are being tested in NCT05461586?

Interventions in NCT05461586: Refractive Technique (MR #1), Refractive Technique (MR #2).

What condition does NCT05461586 study?

NCT05461586 studies Refractive Error.

Is NCT05461586 still recruiting?

NCT05461586 is currently completed. Last updated 6 January 2023.

Last reviewed 2023-01-06 · How we verify

NCT05461586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Investigation of Refraction Techniques

Completed Last updated 6 January 2023

What this trial tests

trial testing Refractive Technique (MR #1) in Refractive Error in 35 participants. Completed in 9 August 2022.

Timeline

14 July 2022

Primary endpoint
9 August 2022

9 August 2022

Quick facts

Lead sponsor	Johnson & Johnson Surgical Vision, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	14 July 2022
Primary completion	9 August 2022
Estimated completion	9 August 2022
Sites	1 location across Australia

Drugs / interventions tested

Refractive Technique (MR #1)
Refractive Technique (MR #2)

Conditions studied

Refractive Error — all drugs for Refractive Error →

Sponsor

Johnson & Johnson Surgical Vision, Inc. — full company profile →

Who can join

Eligibility, any sex, with Refractive Error. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, multi-center, non-interventional, randomized, comparative clinical study to identify an optimal refractive technique that provides maximum plus refractive endpoint for best corrected distance visual acuity (BCDVA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Refractive Error

Currently open trials in the same condition.

NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting

Other Johnson & Johnson Surgical Vision, Inc. trials

Trials by the same sponsor.

NCT07324200 — Objective Assessment of Intraocular Lens Tilt and Decentration · recruiting
NCT07218419 — Comparison of Methods for Assessing Intraocular Lens Position · completed
NCT06797856 — Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer · completed
NCT05090787 — Clinical Investigation of the TECNIS 1-Piece Intraocular Lens · NA · withdrawn
NCT06767319 — Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05461586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Surgical Vision, Inc.
Last refreshed: 6 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05461586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing